100
Participants
Start Date
December 20, 2023
Primary Completion Date
December 4, 2026
Study Completion Date
December 15, 2027
JNJ-88549968
JNJ-88549968 will be administered.
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Charite Campus Benjamin Franklin, Berlin
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Levine Cancer Institute, Charlotte
RECRUITING
Medizinische Hochschule Hannover, Hanover
RECRUITING
Moffit Cancer center, Tampa
RECRUITING
Sarah Cannon Cancer Institute, Nashville
RECRUITING
Policlinico Sant'Orsola Malpighi, Bologna
RECRUITING
Hosp. Clinico Univ. de Valencia, Valencia
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Universitaetsklinikum der RWTH Aachen, Aachen
RECRUITING
Tel Aviv Sourasky Medical Center, Tel Aviv
RECRUITING
Universitaetsklinikum Heidelberg, Heidelberg
RECRUITING
CH LYON SUD - Hematology, Pierre-Bénite
RECRUITING
Hopital Saint Louis, Paris
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
City of Hope, Duarte
RECRUITING
Universitaetsklinikum Regensburg, Regensburg
RECRUITING
Carmel Medical Center, Haifa
RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
Hadassah University Hospita Ein Kerem, Jerusalem
RECRUITING
Princess Margaret Cancer Centre University Health Network, Toronto
RECRUITING
Jewish General Hospital, Montreal
RECRUITING
Hosp. Univ. Germans Trias I Pujol, Badalona
RECRUITING
University College London Hospitals Nhs Foundation Trust, London
RECRUITING
Churchill Hospital, Oxford
Janssen Research & Development, LLC
INDUSTRY